About Alydia Health
In 2010, two biomedical engineering students at Cal Poly decided to enter a competition to design an improved PPH treatment. They set a goal of encouraging natural physiologic recovery, creating a device that was designed to work with the natural contraction of the uterus to rapidly stop bleeding. And so, vacuum-induced uterine tamponade was born.
A visionary team of founders gathered around the product concept and began the journey through research, development and early clinical evaluation. The young company benefited from incubating with the Cal Poly Center for Innovation & Entrepreneurship, and later with the Fogarty Institute for Innovation, before moving out on its own.
Today, Alydia Health is a privately held, venture-backed company headquartered in Menlo Park, California, and its investigational postpartum hemorrhage device is currently being evaluated in the U.S.-based PEARLE study. Our mission is to improve safety in childbirth for all mothers.
Investors & Supporters
The Alydia Health Team
Clinical Research Coordinator
Jan Segnitz, MD
Board of Directors and Advisors
Curt LaBelle, MD, MBA
Managing Partner, Global Health Investment Fund